Aim: The present study endeavours to develop a solid self-microemulsifying nutraceutical drug delivery system for hesperidin (HES) using quality by design (QbD) to improve its biopharmaceutical attributes.
Methods: A 3 full factorial design was employed to study the influence of factors on selected responses. Risk assessment was performed by portraying Ishikawa fishbone diagram and failure mode effect analysis (FMEA). The antidiabetic study was carried on induced diabetic rats.
Results: The optimised liquid SMEDDS-HES (OF) formulation showed emulsification time ( ) = 102.5 ± 2.52 s, globule size ( ) = 225.2 ± 3.40 nm, polydispersity index ( ) = 0.294 ± 0.62, and zeta potential ( ) = -25.4 ± 1.74 mV, respectively. The solid SMEDDS-HES (SOF-7) formulation was characterised by FTIR, PXRD, DSC, and SEM. The shelf life of SOF-7 was found to be 32.88 months. The heamatological and histopathological data of diabetic rats showed prominent antidiabetic activity.
Conclusions: The optimised formulation showed improved dissolution, desired stability, and promising antidiabetic activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/02652048.2020.1851788 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment of Inflammatory Bowel Disease by Using Curcumin-Containing Self-Microemulsifying Delivery System: Macroscopic and Microscopic Analysis.
Pharmaceutics
October 2024
Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo 11562, Egypt.
The lack of local availability for drugs in the colon can be addressed by preparing a self-microemulsifying drug delivery system (SMEDDS) of curcumin (Cur) which is ultimately used for the treatment of inflammatory bowel disease (IBD). From preformulation studies, Lauroglycol FCC (oil), Tween 80 (surfactant), Transcutol HP (co-surfactant), and Avicel (solid carrier) were selected for the preparation of blank liquid and solid Cur-loaded SMEDDSs (S-Cur-SMEDDSs). Z-average size (12.
View Article and Find Full Text PDFDevelopment, Analysis, and Determination of Pharmacokinetic Properties of a Solid SMEDDS of Voriconazole for Enhanced Antifungal Therapy.
Life (Basel)
November 2024
Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Background: Voriconazole is an antifungal drug, which is classified under Bio-Classification System-II and has low water solubility (0.71 mg/mL) and high permeability. Hardly any endeavors have been made to increase the bioavailability of voriconazole.
View Article and Find Full Text PDFDevelopment of Solidified Self-microemulsifying Delivery Systems Containing Tacrolimus for Enhanced Dissolution and Pharmacokinetic Profile.
AAPS J
November 2024
Department of Pharmacy, Fuzong Clinical Medical College of Fujian Medical University (900 Hospital of the Joint Logistics Team), 156 West Second-Ring Road, Fuzhou, 350025, PR China.
Article Synopsis
- - The study investigates improving the delivery of tacrolimus (FK506), an immunosuppressant, by using a self-microemulsifying drug delivery system (SMEDDS) to enhance its solubility and bioavailability.
- - Liquid SMEDDS was solidified using Aeroperl® 300 Pharma, which showed excellent performance in drug dissolution and compatibility, and achieving complete drug release was facilitated by precoating with polyvinylpyrrolidone K30.
- - The resulting hydroxypropyl methylcellulose-based tablets demonstrated a significant increase in bioavailability (179.02%) compared to the marketed formulation Advagraf®, suggesting a promising direction for future SMEDDS applications.
Locally Acting Budesonide-Loaded Solid Self-Microemulsifying Drug Delivery Systems (SMEDDS) for Distal Ulcerative Colitis.
Int J Nanomedicine
November 2024
Department of Anatomical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Background: Budesonide (BUD) is a BCS class II medication with poor water solubility and limited oral bioavailability. In this study, innovative solid self-microemulsifying drug delivery systems (BUD-SMEDDS) were developed for effective local management of distal ulcerative colitis (UC).
Methods: Based on solubility and emulsification tests, the components of the self-microemulsifying drug delivery system (SMEDDS) were Capryol™ 90, Tween 80, and Transcutol HP.
Nanocarrier-Based Delivery Approaches of Mangiferin: An Updated Review on Leveraging Biopharmaceutical Characteristics of the Bioactive.
Curr Pharm Biotechnol
September 2024
Faculty of Pharmacy, Integral University, Lucknow- 226026, India.
In recent years, bioactive constituents from plants have been investigated as an alternative to synthetic approaches of therapeutics. Mangiferin (MGF) is a xanthone glycoside extracted from Mangifera indica and has shown numerous medicinal properties, such as antimicrobial, anti-diarrhoeal, antiviral, anti-inflammatory, antihypertensive, anti-tumours, and anti-diabetic effects. However, there are numerous challenges to its effective therapeutic usage, including its low water solubility, limited absorption, and poor bioavailability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!